Commentary

Video

Dr. Sellinger on private equity acquisition in urology

“Private equity allows an opportunity to provide improved scale with large organization,” says Scott B. Sellinger, MD, FACS.

In this video, Scott B. Sellinger, MD, FACS, highlights the growing trend of private equity acquisition in urology. Sellinger is a urologist at Advanced Urology Institute, an independent, integrated urology practice in Tallahassee, Florida.

Video Transcript:

Private equity in urology has really blown up over the last few years. It has trailed behind some of the other specialties in medicine that have already had similar patterns, so we've learned some from them. We've learned what works and what doesn't work. That's one of the benefits that we have in not being the first in that group. It boils down to [the idea that] like-minded urologists like to be together and work together and continue to find better ways to provide best patient care. We're in a difficult situation right now where our business continues to grow, our workforce is shrinking, and our costs are going up, yet our reimbursements remain fixed or go down. So, we need to be creative and find other ways to have business models that work. Private equity allows an opportunity to provide improved scale with large organization. We can learn from each other in many ways, and I think that so far, it's been very helpful in all regards.

This transcription has been edited for clarity.

Related Videos
Wayne Kuang, MD, answers a question during a Zoom video interview
Raveen Syan, MD, FPMRS, answers a question during a Zoom video interview
Mohamad Baker Berjaoui, MD, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.